Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation.

Long-term immune reconstitution Lymphocyte subset number reconstitution Umbilical cord blood transplantation

Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
26 Feb 2024
Historique:
received: 20 06 2023
accepted: 31 01 2024
revised: 27 01 2024
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: aheadofprint

Résumé

The number of umbilical cord blood transplantation (U-CBT) procedures has been growing annually, but little research has been done on long-term immune recovery after U-CBT. Infection risk is high in U-CBT recipients, and this can be partially attributed to immature immunocompetent cells in umbilical cord blood. In this study, we analyzed lymphocyte subset (LST) number to determine the long-term recovery timeline. We included 36 U-CBT and 10 unrelated bone marrow transplantation (U-BMT) recipients who survived more than 2 years after transplantation, and followed them for up to 10 years post-transplant. Recovery kinetics in the early phase post-transplant was different for each LST. Recovery of CD19

Identifiants

pubmed: 38407785
doi: 10.1007/s12185-024-03727-x
pii: 10.1007/s12185-024-03727-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Japanese Society of Hematology.

Références

Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface Bone Marrow Transplant. 2009;44(8):453–5.
doi: 10.1038/bmt.2009.254 pubmed: 19861977
Valiathan R, Deeb K, Diamante M, Ashman M, Sachdeva N, Asthana D. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Immunobiology. 2014;219(7):487–96.
doi: 10.1016/j.imbio.2014.02.010 pubmed: 24661720
Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B, et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood. 2000;96(6):2299–303.
doi: 10.1182/blood.V96.6.2299 pubmed: 10979980
Lindemans CA, Chiesa R, Amrolia PJ, Rao K, Nikolajeva O, de Wildt A, et al. Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood. 2014;123(1):126–32.
doi: 10.1182/blood-2013-05-502385 pubmed: 24184682
Nakatani K, Imai K, Shigeno M, Sato H, Tezuka M, Okawa T, et al. Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation. Bone Marrow Transplant. 2014;49(9):1155–61.
doi: 10.1038/bmt.2014.123 pubmed: 24978139
Shima T, Miyamoto T, Kikushige Y, Mori Y, Kamezaki K, Takase K, et al. Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantation. Blood. 2013;121(5):840–8.
doi: 10.1182/blood-2012-02-409607 pubmed: 23233661
Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130(3):388–93.
doi: 10.1016/S0022-3476(97)70200-2 pubmed: 9063413
Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 1992;89(21):10006–10.
doi: 10.1073/pnas.89.21.10006 pubmed: 1438190 pmcid: 50266
Grindebacke H, Stenstad H, Quiding-Jarbrink M, Waldenstrom J, Adlerberth I, Wold AE, et al. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol. 2009;183(7):4360–70.
doi: 10.4049/jimmunol.0901091 pubmed: 19734224
Matsuno N, Yamamoto H, Watanabe N, Uchida N, Ota H, Nishida A, et al. Rapid T-cell chimerism switch and memory T-cell expansion are associated with pre-engraftment immune reaction early after cord blood transplantation. Br J Haematol. 2013;160(2):255–8.
doi: 10.1111/bjh.12097 pubmed: 23116322
Yuasa M, Asano-Mori Y, Mitsuki T, Yamaguchi K, Kageyama K, Kaji D, et al. Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation. Br J Haematol. 2021;193(2):423–7.
doi: 10.1111/bjh.17376 pubmed: 33751547
Politikos I, Lavery JA, Hilden P, Cho C, Borrill T, Maloy MA, et al. Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin. Blood Adv. 2020;4(1):191–202.
doi: 10.1182/bloodadvances.2019000836 pubmed: 31935291 pmcid: 6960461
Moretta A, Andriolo G, Lisini D, Martinetti M, Pasi A, Rebulla P, et al. In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation. Biol Blood Marrow Transplant. 2012;18(7):1108–18.
doi: 10.1016/j.bbmt.2011.12.586 pubmed: 22227591

Auteurs

Keiko Tsumita (K)

Department of Clinical Laboratory, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.

Shinsuke Takagi (S)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.
Okinaka Memorial Institute for Medical Research, Tokyo, Japan.

Yuki Asano-Mori (Y)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.
Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.

Otoya Watanabe (O)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Michiho Shindo (M)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Kyosuke Yamaguchi (K)

Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.

Mitsuhiro Yuasa (M)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Kosei Kageyama (K)

Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.

Daisuke Kaji (D)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.

Yuki Taya (Y)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.

Aya Nishida (A)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Kazuya Ishiwata (K)

Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.

Hisashi Yamamoto (H)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.

Hideki Araoka (H)

Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.

Go Yamamoto (G)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Shigeyoshi Makino (S)

Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.

Atsushi Wake (A)

Center for Long-Term Follow-Up After Hematopoietic Cell Transplantation, Toranomon Hospital, Tokyo, Japan.
Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.

Naoyuki Uchida (N)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Okinaka Memorial Institute for Medical Research, Tokyo, Japan.

Shuichi Taniguchi (S)

Department of Hematology, Toranomon Hospital, Tokyo, Japan.

Yukako Koike (Y)

Department of Clinical Laboratory, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan. yukako-tky@umin.ac.jp.

Classifications MeSH